Subsequent Events (Details) (USD $) Share data in Millions, unless otherwise specified	3 Months Ended		0 Months Ended			3 Months Ended														0 Months Ended	12 Months Ended	0 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	May 06, 2014 Subsequent Event [Member]	May 09, 2014 Subsequent Event [Member]	Apr. 30, 2014 Subsequent Event [Member]	Mar. 31, 2014 1.75% Convertible Senior Subordinated Notes Due April 15, 2015 [Member]	Apr. 30, 2014 1.75% Convertible Senior Subordinated Notes Due April 15, 2015 [Member] Subsequent Event [Member]	Mar. 31, 2014 7.00% Senior Notes Due 2019 [Member]	Dec. 31, 2013 7.00% Senior Notes Due 2019 [Member]	May 06, 2014 7.00% Senior Notes Due 2019 [Member] Subsequent Event [Member]	Mar. 31, 2014 7.00% Senior Notes Due 2020 [Member]	Dec. 31, 2013 7.00% Senior Notes Due 2020 [Member]	May 06, 2014 7.00% Senior Notes Due 2020 [Member] Subsequent Event [Member]	Mar. 31, 2014 7.25% Senior Notes Due 2022 [Member]	Dec. 31, 2013 7.25% Senior Notes Due 2022 [Member]	May 06, 2014 7.25% Senior Notes Due 2022 [Member] Subsequent Event [Member]	May 06, 2014 Finance Notes Due 2019 [Member] Subsequent Event [Member]	May 06, 2014 Finance Notes Due 2020 [Member] Subsequent Event [Member]	May 06, 2014 Finance Notes Due 2022 [Member] Subsequent Event [Member]	Apr. 24, 2014 Sumavel DosePro [Member] Subsequent Event [Member]	Dec. 31, 2013 Grupo Farmaceutico Somar [Member]	Apr. 30, 2014 Grupo Farmaceutico Somar [Member] Subsequent Event [Member]	Apr. 30, 2014 Vaginal mesh cases [Member] AMS [Member] Subsequent Event [Member] settled_cases
Business Acquisition [Line Items]
Convertible Note Gross						$ 379,500,000	$ 139,500,000
Interest Rate (percent)						1.75%		7.00%		7.00%	7.00%		7.00%	7.25%		7.25%
Senior notes, gross								500,000,000	500,000,000	482,000,000	400,000,000	400,000,000	393,000,000	400,000,000	400,000,000	396,300,000	481,900,000	393,000,000	396,300,000
Notes outstanding after settlement of exchange offers										18,000,000			7,000,000			3,700,000
Payment for Consent Solicitations			11,700,000
Debt Instrument, Maturity Date						Apr. 15, 2015
Option to purchase, shares	13.0
Debt Instrument, Repurchased Face Amount					240,000,000
Debt Instrument, Repurchase Amount					450,000,000
Payments to acquire business																				85,000,000
Business Combination, Consideration Transferred, Other																						268,800,000
Revenues	594,609,000	658,494,000																			100,000,000
Loss Contingency, Claims Settled, Number																							20,000
Accrued Excise Taxes				$ 60,000,000